Femasys Inc
FEMY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001339005
In the last 90 days, Femasys Inc insiders filed 5 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $8.65M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Femasys Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +1 vs. Q1 2022
- Shares held
- 831.7K
- +10.0K (+1.2%) vs. Q1 2022
- Total value
- $2.00M
- +$148.2K (+8.0%) vs. Q1 2022
- New holders
- 6
- 6 more added
- Sold out
- 5
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FEMY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $8.65M |
| Q1 2026 | 36 | $3.98M |
| Q4 2025 | 39 | $2.88M |
| Q3 2025 | 32 | $1.33M |
| Q2 2025 | 36 | $3.51M |
| Q1 2025 | 30 | $4.88M |
| Q4 2024 | 29 | $2.62M |
| Q3 2024 | 27 | $1.86M |
| Q2 2024 | 28 | $1.87M |
| Q1 2024 | 23 | $2.36M |
| Q4 2023 | 24 | $1.44M |
| Q3 2023 | 28 | $4.80M |
| Q2 2023 | 22 | $624.6K |
| Q1 2023 | 19 | $1.28M |
| Q4 2022 | 19 | $898.3K |
| Q3 2022 | 17 | $1.01M |
| Q2 2022 | 18 | $2.00M |
| Q1 2022 | 17 | $1.86M |
| Q4 2021 | 16 | $2.02M |
| Q3 2021 | 10 | $3.60M |
| Q2 2021 | 11 | $4.90M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Femasys Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 32 | $0 | 0.00% | −88−73.3% | Reduced |
| Wells Fargo & Company | 1,018 | $2.00K | 0.00% | +1,001+5,888.2% | Added |
| UBS Group AG | 1,296 | $3.00K | 0.00% | −65,406−98.1% | Reduced |
| Morgan Stanley | 1,565 | $4.00K | 0.00% | +37+2.4% | Added |
| Bank of America Corp | 3,048 | $7.00K | 0.00% | +3,048 | New |
| Citigroup Inc | 8,849 | $21.0K | 0.00% | +8,849 | New |
| Storebrand Asset Management AS | 9,912 | $23.9K | 0.00% | +6,238+169.8% | Added |
| Tower Research Capital LLC (TRC) | 10,060 | $24.0K | 0.00% | +8,822+712.6% | Added |
| StoneX Group Inc. | 10,227 | $24.6K | 0.00% | +10,227 | New |
| Citadel Advisors LLC | 15,787 | $38.0K | 0.00% | +15,787 | New |
| Virtu Financial LLC | 16,002 | $39.0K | 0.00% | +16,002 | New |
| LPL Financial LLC | 21,032 | $51.0K | 0.00% | +21,032 | New |
| Oppenheimer & Co Inc | 23,860 | $58.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 55,158 | $133.0K | 0.00% | 00.0% | Unchanged |
| Tri Locum Partners LP | 83,831 | $202.0K | 0.08% | −4,121−4.7% | Reduced |
| Vanguard Group Inc | 119,185 | $287.0K | 0.00% | 00.0% | Unchanged |
| Clear Creek Financial Management, LLC | 150,801 | $363.0K | 0.08% | +64,500+74.7% | Added |
| CM Management, LLC | 300,000 | $723.0K | 0.77% | +75,000+33.3% | Added |
| First National Corp | 0 | $0 | 0.00% | −74,296−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −29,881−100.0% | Sold out |
| Freedman Financial Associates, Inc. | 0 | $0 | 0.00% | −21,032−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −13,686−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |